Medpace Holdings, Inc. Common Stock (MEDP) Price and Market Data

Medpace Holdings, Inc. is a late-stage contract research organization (CRO) providing full-service drug development and clinical trial solutions to small and midsize biotechnology, pharmaceutical, and medical device companies. The company also delivers ancillary services such as bioanalytical laboratory support and imaging capabilities. Founded more than 30 years ago, Medpace employs over 5,400 people across 40 countries. Headquartered in Cincinnati, Ohio, its operations are primarily concentrated in the United States, with additional presence in Europe, Asia, South America, Africa, and Australia. Global private equity firm Cinven acquired Medpace for $915 million in 2014 and exited its investment in 2018.